Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study-Reference-Cited by-同舟云学术

Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study

Published:2019 Issue:5 Volume:43 Page:640
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Chung Yoo-Ri¹^ORCID,Ha Kyoung Hwa²³,Kim Hyeon Chang⁴,Park Sang Jun⁵,Lee Kihwang¹^ORCID,Kim Dae Jung²³^ORCID

Affiliation:

1. Department of Ophthalmology, Ajou University School of Medicine, Suwon, Korea.

2. Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.

3. Department of Cardiovascular and Metabolic Disease Etiology Research Center, Ajou University School of Medicine, Suwon, Korea.

4. Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Funder

Korea Health Industry Development Institute

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2018.0137

Reference37 articles.

1. Advances in our understanding of diabetic retinopathy

2. Pathophysiology and treatment of diabetic retinopathy

3. Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial

4. Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5)

5. Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening Retinopathy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study;Diabetes, Obesity and Metabolism;2024-07-19

2. Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment;Ophthalmology Science;2024-07

3. Association between dipeptidyl peptidase-4 inhibitor use and diabetic retinopathy: a systematic review and meta-analysis of real-world studies;BMC Ophthalmology;2024-06-28

4. Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2024-03-20

5. Weight loss, bariatric surgery, and novel antidiabetic drugs effects on diabetic retinopathy: a review;Current Opinion in Ophthalmology;2024-01-30